118 related articles for article (PubMed ID: 17465216)
1. EGFR and VEGFR2 protein expressions in bone metastases of clear cell renal cancer.
Badalian G; Derecskei K; Szendroi A; Szendroi M; Tímár J
Anticancer Res; 2007; 27(2):889-94. PubMed ID: 17465216
[TBL] [Abstract][Full Text] [Related]
2. Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.
Merseburger AS; Hennenlotter J; Simon P; Kruck S; Koch E; Horstmann M; Kuehs U; Küfer R; Stenzl A; Kuczyk MA
Anticancer Res; 2005; 25(3B):1901-7. PubMed ID: 16158924
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Id-1 and its association with EGFR in renal cell cancer.
Li X; Zhang Z; Xin D; Chua CW; Wong YC; Leung SC; Na Y; Wang X
Histopathology; 2007 Mar; 50(4):484-90. PubMed ID: 17448024
[TBL] [Abstract][Full Text] [Related]
4. The expression of ketohexokinase is diminished in human clear cell type of renal cell carcinoma.
Hwa JS; Kim HJ; Goo BM; Park HJ; Kim CW; Chung KH; Park HC; Chang SH; Kim YW; Kim DR; Cho GJ; Choi WS; Kang KR
Proteomics; 2006 Feb; 6(3):1077-84. PubMed ID: 16372272
[TBL] [Abstract][Full Text] [Related]
5. Renal papillary adenoma--a putative precursor of papillary renal cell carcinoma.
Wang KL; Weinrach DM; Luan C; Han M; Lin F; Teh BT; Yang XJ
Hum Pathol; 2007 Feb; 38(2):239-46. PubMed ID: 17056094
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
7. Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Riesenberg R; Weiler C; Spring O; Eder M; Buchner A; Popp T; Castro M; Kammerer R; Takikawa O; Hatz RA; Stief CG; Hofstetter A; Zimmermann W
Clin Cancer Res; 2007 Dec; 13(23):6993-7002. PubMed ID: 18056175
[TBL] [Abstract][Full Text] [Related]
8. Lapatinib versus hormone therapy in patients with advanced renal cell carcinoma: a randomized phase III clinical trial.
Ravaud A; Hawkins R; Gardner JP; von der Maase H; Zantl N; Harper P; Rolland F; Audhuy B; Machiels JP; Pétavy F; Gore M; Schöffski P; El-Hariry I
J Clin Oncol; 2008 May; 26(14):2285-91. PubMed ID: 18467719
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor positivity in angiomyolipoma contiguous to renal cell carcinoma: report of two cases with immunohistochemical analysis.
Amin K; O'Neil MF; Fan F; McGregor DH
Ann Clin Lab Sci; 2011; 41(1):56-60. PubMed ID: 21325256
[TBL] [Abstract][Full Text] [Related]
10. The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell carcinoma: a call for standardized methods for immunohistochemical evaluation.
Cohen D; Lane B; Jin T; Magi-Galluzzi C; Finke J; Rini BI; Bukowski RM; Zhou M
Clin Genitourin Cancer; 2007 Mar; 5(4):264-70. PubMed ID: 17553206
[TBL] [Abstract][Full Text] [Related]
11. Expression of two isozymes of acyl-coenzyme A: cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma.
Matsumoto K; Fujiwara Y; Nagai R; Yoshida M; Ueda S
Int J Urol; 2008 Feb; 15(2):166-70. PubMed ID: 18269457
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of CD95 receptor expression in clear cell renal carcinomas.
Ramp U; Bretschneider U; Ebert T; Karagiannidis C; Willers R; Gabbert HE; Gerharz CD
Hum Pathol; 2003 Feb; 34(2):174-9. PubMed ID: 12612886
[TBL] [Abstract][Full Text] [Related]
13. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
Rivet J; Mourah S; Murata H; Mounier N; Pisonero H; Mongiat-Artus P; Teillac P; Calvo F; Janin A; Dosquet C
Cancer; 2008 Jan; 112(2):433-42. PubMed ID: 18041056
[TBL] [Abstract][Full Text] [Related]
14. Down-regulated expression of RhoA in human conventional renal cell carcinoma.
Pu YS; Wang CW; Liu GY; Kuo YZ; Huang CY; Kang WY; Shun CT; Lin CC; Wu WJ; Hour TC
Anticancer Res; 2008; 28(4B):2039-43. PubMed ID: 18751372
[TBL] [Abstract][Full Text] [Related]
15. Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.
Mikami S; Katsube K; Oya M; Ishida M; Kosaka T; Mizuno R; Mochizuki S; Ikeda T; Mukai M; Okada Y
J Pathol; 2009 Aug; 218(4):530-9. PubMed ID: 19455604
[TBL] [Abstract][Full Text] [Related]
16. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues.
Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S
J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570
[TBL] [Abstract][Full Text] [Related]
17. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile.
Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB
Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of glutathione s-transferase alpha in clear cell renal cell carcinoma.
Chuang ST; Chu P; Sugimura J; Tretiakova MS; Papavero V; Wang K; Tan MH; Lin F; Teh BT; Yang XJ
Am J Clin Pathol; 2005 Mar; 123(3):421-9. PubMed ID: 15716239
[TBL] [Abstract][Full Text] [Related]
19. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
20. Renal cell carcinoma bone metastasis--elucidating the molecular targets.
Weber K; Doucet M; Kominsky S
Cancer Metastasis Rev; 2007 Dec; 26(3-4):691-704. PubMed ID: 17768599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
